Search Results

FDA Approves First Adjuvant Therapy for Most Common Type of Lung Cancer

Today, the U.S. Food and Drug Administration approved Tagrisso (osimertinib) as the first adjuvant treatment for patients with non-small cell lung cancer whose ...
Dec 19